Cargando…
Implications of NQO1 in cancer therapy
NAD(P)H:quinone oxidoreductase (NQO1), an obligatory two-electron reductase, is a ubiquitous cytosolic enzyme that catalyzes the reduction of quinone substrates. The NQO1- mediated two-electron reduction of quinones can be either chemoprotection/detoxification or a chemotherapeutic response, dependi...
Autores principales: | Oh, Eun-Taex, Park, Heon Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular
Biology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911202/ https://www.ncbi.nlm.nih.gov/pubmed/26424559 http://dx.doi.org/10.5483/BMBRep.2015.48.11.190 |
Ejemplares similares
-
NQO1-induced activation of AMPK contributes to cancer cell death by oxygen-glucose deprivation
por: Lee, Hyemi, et al.
Publicado: (2015) -
NQO1 regulates cell cycle progression at the G2/M phase
por: Oh, Eun-Taex, et al.
Publicado: (2023) -
The diverse functionality of NQO1 and its roles in redox control
por: Ross, David, et al.
Publicado: (2021) -
NQO1 inhibits proteasome-mediated degradation of HIF-1α
por: Oh, Eun-Taex, et al.
Publicado: (2016) -
Stem cell-derived extracellular vesicle therapy for acute brain insults and neurodegenerative diseases
por: Bang, Oh Young, et al.
Publicado: (2022)